×

This drug was key driver of Celegene deal: CEO

7:52 AM ET Wed, 15 July 2015

CNBC's Meg Tirrell and Robert Hugin, Celgene chairman & CEO, discuss the drugmaker's $7.3 billion bid for Receptos in an effort to acquire a third autoimmune drug.